Apr 7 2010
On the road to global economic recovery, the BRIC countries (Brazil, Russia, India and China) are setting up a new scene. Brazil, in particular, is the 9th economy in the world and is expected to reach the 8th position by 2012. New opportunities set a promising healthcare market perspective with a strong potential for further growth.
New analysis from Frost & Sullivan, "Brazil Healthcare Outlook: Analysis of Best Opportunities," finds the Brazil healthcare market earned revenues of $22.1 billion in 2009 and estimates this to reach $129.9 billion in 2012, which represents a 35% growth in 3 years, 4.1% above global market growth.
By 2012 it is expected that the population older than 60 years will be around 24 million in Brazil. In response to the increased demand driven by a higher life expectancy, healthcare total expenditure is anticipated to reach almost USD 200 billion over the next 5 years. Also, as the elected host of the World Cup in 2014 and the Olympic Games in 2016, Brazil is likely to invest massively in new infrastructure starting this year. Moreover, Brazil Home Care market is estimated to be worth $250 million in 2012.
The positive healthcare market outlook is also based on the increasing upper-lower social class purchase power, which changes healthcare services configuration and market strategies. "The access to medical insurance is growing in Brazil, driven by the increase of formal jobs. Healthcare insurance companies are creating new modalities of plans and investing on 'verticalization' processes to reduce costs and attend the emerging class C," observes Luisa Woge, Frost & Sullivan Senior Consultant. "The incremental demand for private sector will impact the volume of routine hospital procedures, such as ambulatory exams, ultrasound, X-ray, among others."
Hospital Information and Picture Archiving and Communication Systems (HIS & PACS) markets encompass the highest growth rates of the healthcare market in Brazil, with compound annual growth rates of around 30%. Moreover, given the size of Brazilian populations, vaccines and biologics show a huge potential within the pharmaceutical market.
If you are interested in more information on Frost & Sullivan's analysis of the best opportunities in the Brazilian Healthcare industry, send an email to Catalina Rossini, Corporate Communications, at [email protected], with your full name, company name, title, telephone number, company email address, company Web site, and country.
The complete outlook includes an extensive revision on public and private investment scenarios, in-depth sector analysis that focuses on the drivers and restraints for Brazil Medical Devices, Clinical Diagnostics; Life sciences and Health IT Markets, and all the necessary information for investment in the Brazil Healthcare market in the following two years.
Interviews with the press are available.